Mereo BioPharma (MREO) Current Taxes (2021)

Mereo BioPharma (MREO) reported Current Taxes of $2.1 million for Q4 2021.

Mereo BioPharma (MREO) Current Taxes (2021) Analysis & Trends

Mereo BioPharma (MREO) has 1 years of Current Taxes data on file, last reported at $2.1 million in Q4 2021.

  • Current Taxes for Q4 2021 came in at $2.1 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was $2.1 million (changed N/A YoY), and the FY2021 annual result was $2.1 million, changed N/A from the prior year.
  • Current Taxes steadied at $2.1 million in Q4 2021 per MREO's latest filing.
  • Over five years, Current Taxes peaked at $2.1 million in Q4 2021 and troughed at $2.1 million in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 10,460.56
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 19.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Mereo BioPharma 252.49 Mn 252.49 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2021 2.05 Mn